|
|
||||||||
a BresaGen Inc., Athens, Georgia, USA;
b Department of Genetics, University of Georgia, Athens, Georgia, USA;
c Institute of Molecular Medicine and Genetics and
d Departments of Pharmacology and Toxicology, Medical College of Georgia, Augusta, Georgia, USA;
e BresaGen Ltd., Thebarton, Adelaide, Australia;
f Medical Research Service, Augusta Veterans Affairs Medical Center, Augusta, Georgia, USA
Key Words. Embryoid bodies • ES cells • Differentiation • Neural differentiation • Serum-free medium • Real-time RT-PCR
Correspondence: Thomas C. Schulz, Ph.D., BresaGen Inc., 111 Riverbend Rd., Athens, Georgia, 30605, USA. Telephone: 706-613-9878; Fax: 706-613-9879; e-mail: tschulz{at}novocell.com; and Brian G. Condie, Ph.D., Department of Genetics, Life Sciences Building, University of Georgia, Athens, GA 30602, USA. Telephone: 706-542-1431; Fax: 706-583-0691; e-mail: bcondie{at}uga.edu
The use of human embryonic stem cells (hESCs) as a source of dopaminergic neurons for Parkinsons disease cell therapy will require the development of simple and reliable cell differentiation protocols. The use of cell cocultures, added extracellular signaling factors, or transgenic approaches to drive hESC differentiation could lead to additional regulatory as well as cell production delays for these therapies. Because the neuronal cell lineage seems to require limited or no signaling for its formation, we tested the ability of hESCs to differentiate to form dopamine-producing neurons in a simple serum-free suspension culture system. BG01 and BG03 hESCs were differentiated as suspension aggregates, and neural progenitors and neurons were detecz after 24 weeks. Plated neurons responded appropriately to electrophysiological cues. This differentiation was inhibited by early exposure to bone morphogenic protein (BMP)-4, but a pulse of BMP-4 from days 5 to 9 caused induction of peripheral neuronal differentiation. Real-time polymerase chain reaction and whole-mount immunocytochemistry demonstrated the expression of multiple markers of the midbrain dopaminergic phenotype in serum-free differentiations. Neurons expressing tyrosine hydroxylase (TH) were killed by 6-hydroxydopamine (6-OHDA), a neurotoxic catecholamine. Upon plating, these cells released dopamine and other catecholamines in response to K+ depolarization. Surviving TH+ neurons, derived from the cells differentiated in serum-free suspension cultures, were detected 8 weeks after transplantation into 6-OHDAlesioned rat brains. This work suggests that hESCs can differentiate in simple serum-free suspension cultures to produce the large number of cells required for transplantation studies.
This article has been cited by other articles:
![]() |
M. S. Cho, Y.-E. Lee, J. Y. Kim, S. Chung, Y. H. Cho, D.-S. Kim, S.-M. Kang, H. Lee, M.-H. Kim, J.-H. Kim, et al. Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells PNAS, March 4, 2008; 105(9): 3392 - 3397. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yang, Z.-J. Zhang, M. Oldenburg, M. Ayala, and S.-C. Zhang Human Embryonic Stem Cell-Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats Stem Cells, January 1, 2008; 26(1): 55 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Joannides, D. J. Webber, O. Raineteau, C. Kelly, K.-A. Irvine, C. Watts, A. E. Rosser, P. J. Kemp, W. F. Blakemore, A. Compston, et al. Environmental signals regulate lineage choice and temporal maturation of neural stem cells from human embryonic stem cells Brain, May 1, 2007; 130(5): 1263 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Joannides, C. Fiore-Heriche, A. A. Battersby, P. Athauda-Arachchi, I. A. Bouhon, L. Williams, K. Westmore, P. J. Kemp, A. Compston, N. D. Allen, et al. A Scaleable and Defined System for Generating Neural Stem Cells from Human Embryonic Stem Cells Stem Cells, March 1, 2007; 25(3): 731 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Sonntag, J. Pruszak, T. Yoshizaki, J. van Arensbergen, R. Sanchez-Pernaute, and O. Isacson Enhanced Yield of Neuroepithelial Precursors and Midbrain-Like Dopaminergic Neurons from Human Embryonic Stem Cells Using the Bone Morphogenic Protein Antagonist Noggin Stem Cells, February 1, 2007; 25(2): 411 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Brimble, E. S. Sherrer, E. W. Uhl, E. Wang, S. Kelly, A. H. Merrill Jr., A. J. Robins, and T. C. Schulz The Cell Surface Glycosphingolipids SSEA-3 and SSEA-4 Are Not Essential for Human ESC Pluripotency Stem Cells, January 1, 2007; 25(1): 54 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Noggle, D. Weiler, and B. G. Condie Notch Signaling Is Inactive but Inducible in Human Embryonic Stem Cells Stem Cells, July 1, 2006; 24(7): 1646 - 1653. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brederlau, A. S. Correia, S. V. Anisimov, M. Elmi, G. Paul, L. Roybon, A. Morizane, F. Bergquist, I. Riebe, U. Nannmark, et al. Transplantation of Human Embryonic Stem Cell-Derived Cells to a Rat Model of Parkinson's Disease: Effect of In Vitro Differentiation on Graft Survival and Teratoma Formation Stem Cells, June 1, 2006; 24(6): 1433 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Trounson The Production and Directed Differentiation of Human Embryonic Stem Cells Endocr. Rev., April 1, 2006; 27(2): 208 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-W. Kim, S. Chung, M. Hwang, A. Ferree, H.-C. Tsai, J.-J. Park, S. Chung, T. S. Nam, U. J. Kang, O. Isacson, et al. Stromal Cell-Derived Inducing Activity, Nurr1, and Signaling Molecules Synergistically Induce Dopaminergic Neurons from Mouse Embryonic Stem Cells Stem Cells, March 1, 2006; 24(3): 557 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Smukler, S. B. Runciman, S. Xu, and D. van der Kooy Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences J. Cell Biol., January 3, 2006; 172(1): 79 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pomp, I. Brokhman, I. Ben-Dor, B. Reubinoff, and R. S. Goldstein Generation of Peripheral Sensory and Sympathetic Neurons and Neural Crest Cells from Human Embryonic Stem Cells Stem Cells, August 1, 2005; 23(7): 923 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yan, D. Yang, E. D. Zarnowska, Z. Du, B. Werbel, C. Valliere, R. A. Pearce, J. A. Thomson, and S.-C. Zhang Directed Differentiation of Dopaminergic Neuronal Subtypes from Human Embryonic Stem Cells Stem Cells, June 1, 2005; 23(6): 781 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. ARENAS Engineering a Dopaminergic Phenotype in Stem/Precursor Cells: Role of Nurr1, Glia-Derived Signals, and Wnts Ann. N.Y. Acad. Sci., May 1, 2005; 1049(1): 51 - 66. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
